Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

A Bioequivalence Comparison at Steady State between the Newly Developed Once-Daily Extended Release Tablet Formulation and the Approved Twice-Daily Tablet Formulation of Deutetrabenazine